Vmn1r1, a member of the vomeronasal receptor family, is a crucial molecular player in the intricate system of chemical communication that governs social behaviors in various species. Primarily expressed in the vomeronasal organ, this receptor serves as a specialized detector of pheromones-biochemical substances that convey important information about an organism's reproductive status, social hierarchy, and territorial boundaries. The functional significance of Vmn1r1 lies in its ability to recognize and transduce these chemical cues, triggering specific neural responses that modulate innate behaviors essential for species survival. The primary function of Vmn1r1 involves the detection of pheromones, which are vital for mediating social behaviors such as mating rituals, territorial marking, and hierarchical interactions. As part of the vomeronasal sensory system, Vmn1r1 responds to diverse chemical stimuli, translating them into neural signals that influence instinctive behaviors critical for reproductive success and social cohesion. This receptor plays an integral role in the communication between conspecifics, allowing organisms to respond appropriately to chemical cues in their environment. The specificity of Vmn1r1 in recognizing particular pheromones underscores its importance in shaping social dynamics and facilitating crucial aspects of species-specific behavior.
Inhibition of Vmn1r1 involves intricate signaling pathways and molecular mechanisms that indirectly modulate its function. Chemical compounds targeting key cellular pathways, such as VEGF signaling, MAPK cascades, and PI3K-Akt pathways, exert their influence on Vmn1r1 by disrupting downstream signaling events associated with the receptor. Inhibition may occur through the interference with tyrosine kinases, SRC kinases, or other intracellular mediators that are part of the broader signaling network implicated in vomeronasal receptor function. These pathways, once perturbed by specific inhibitors, may alter cellular processes related to Vmn1r1 activity, impacting its ability to transduce pheromone signals and, consequently, modifying innate behavioral responses. Understanding these indirect mechanisms of inhibition provides insights into the regulatory complexity of vomeronasal receptor function and the intricate interplay between chemical signaling and behavior in the animal kingdom.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
SRC kinase inhibitor affecting cellular signaling cascades. Dasatinib inhibits SRC kinases, indirectly impacting Vmn1r1 by interfering with downstream signaling pathways associated with cellular processes relevant to vomeronasal receptor function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor affecting MAPK signaling pathways. SB203580 inhibits p38 MAPK, indirectly influencing Vmn1r1 through modulation of MAPK signaling cascades, potentially altering cellular processes related to vomeronasal receptor function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor affecting PI3K-Akt signaling. Wortmannin inhibits PI3K, indirectly influencing Vmn1r1 by disrupting the PI3K-Akt pathway and potentially modulating cellular processes associated with vomeronasal receptor function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor affecting cytoskeletal dynamics. Y-27632 inhibits ROCK, indirectly influencing Vmn1r1 by modulating cytoskeletal dynamics, potentially altering cellular processes relevant to vomeronasal receptor function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor affecting the MAPK signaling pathway. SP600125 inhibits JNK, indirectly influencing Vmn1r1 through modulation of the MAPK signaling pathway, potentially altering cellular processes relevant to vomeronasal receptor function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor affecting PI3K-Akt signaling. LY294002 inhibits PI3K, indirectly influencing Vmn1r1 by disrupting the PI3K-Akt pathway and potentially modulating cellular processes associated with vomeronasal receptor function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
SRC kinase inhibitor affecting cellular signaling cascades. PP2 inhibits SRC kinases, indirectly impacting Vmn1r1 by interfering with downstream signaling pathways associated with cellular processes relevant to vomeronasal receptor function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor affecting the MAPK signaling pathway. PD98059 inhibits MEK, indirectly influencing Vmn1r1 by disrupting the MAPK signaling pathway, potentially modulating cellular processes associated with vomeronasal receptor function. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
p38 MAPK inhibitor affecting MAPK signaling pathways. SB202190 inhibits p38 MAPK, indirectly influencing Vmn1r1 through modulation of MAPK signaling cascades, potentially altering cellular processes relevant to vomeronasal receptor function. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $176.00 $235.00 $281.00 $339.00 | 9 | |
PI3K inhibitor affecting PI3K-Akt signaling. BKM120 inhibits PI3K, indirectly influencing Vmn1r1 by disrupting the PI3K-Akt pathway and potentially modulating cellular processes associated with vomeronasal receptor function. | ||||||